Sputnik V developer says interval between vaccine’s two doses can range from 21 days to 3 months
Sputnik V developer Gamaleya Research Centre has said that it is up to India to decide the interval between the two doses of the Russian Covid-19 vaccine, which it has approved for emergency use in the country.
Other Pharmaceuticals Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma
